Oyster Point Pharma Inc. (OYST) NASDAQ
$11.17 - (-)
Market Cap: -
As of 12/30/22 12:00 AM EST. Market closed.
Oyster Point Pharma Inc. (OYST)
NASDAQ
$11.17
- (-)
Market Cap: -
As of 12/30/22 12:00 AM EST. Market closed.
Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry ... read more
Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. In pre-clinical and clinical studies, OC-01 (varenicline) nasal spray was shown to have a novel mechanism of action via activation of the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the lacrimal functional unit. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Nau Jeffrey | President and CEO | Jan 29, 2022 | Option Exercise | $11.70 | 2,607 | 30,502 | 148,713 | Jan 04, 2023, 05:06 PM |
Lochner Daniel | Chief Financial Officer | Jan 29, 2022 | Option Exercise | $11.70 | 938 | 10,975 | 76,525 | Jan 04, 2023, 05:04 PM |
Nau Jeffrey | President and CEO | Dec 01, 2022 | Option Exercise | $11.20 | 8,938 | 100,106 | 148,660 | Dec 06, 2022, 07:05 PM |
Lochner Daniel | Chief Financial Officer | Dec 01, 2022 | Option Exercise | $11.20 | 3,258 | 36,490 | 74,463 | Dec 06, 2022, 08:50 AM |
Nau Jeffrey | President and CEO | Dec 01, 2022 | Option Exercise | $11.20 | 6,217 | 69,630 | 151,381 | Dec 05, 2022, 05:36 PM |
Lochner Daniel | Chief Financial Officer | Nov 01, 2021 | Option Exercise | $11.51 | 8,590 | 98,871 | 58,221 | Nov 02, 2021, 05:49 PM |
Nau Jeffrey | President and CEO | Oct 21, 2021 | Option Exercise | $1.02 | 50,000 | 51,000 | 110,898 | Oct 22, 2021, 04:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 18, 2021 | Sale | $14.84 | 550,000 | 8,160,736 | 1,057,976 | Oct 20, 2021, 04:38 PM |
LINK WILLIAM J PHD | Director | Oct 18, 2021 | Sale | $14.84 | 550,000 | 8,160,736 | 1,057,976 | Oct 20, 2021, 04:32 PM |
Ozawa Clare | Director | Oct 18, 2021 | Sale | $14.84 | 550,000 | 8,160,736 | 1,057,976 | Oct 20, 2021, 04:31 PM |
Lochner Daniel | Chief Financial Officer | Sep 02, 2021 | Option Exercise | $11.51 | 7,500 | 86,325 | 49,631 | Sep 07, 2021, 08:03 AM |
Nau Jeffrey | President and CEO | Sep 01, 2021 | Option Exercise | $1.02 | 10,000 | 10,200 | 60,898 | Sep 01, 2021, 06:00 PM |
Lochner Daniel | Chief Financial Officer | Jul 28, 2021 | Option Exercise | $11.51 | 7,500 | 86,325 | 42,131 | Jul 29, 2021, 05:05 PM |
Nau Jeffrey | President and CEO | Apr 02, 2021 | Option Exercise | $1.02 | 10,000 | 10,200 | 50,898 | Apr 02, 2021, 02:11 PM |
Lochner Daniel | Chief Financial Officer | Feb 24, 2021 | Option Exercise | $11.51 | 9,109 | 104,845 | 34,631 | Feb 26, 2021, 07:50 PM |
Nau Jeffrey | President and CEO | Feb 19, 2021 | Option Exercise | $1.02 | 10,000 | 10,200 | 40,898 | Feb 23, 2021, 08:13 PM |
Lochner Daniel | Chief Financial Officer | Sep 25, 2020 | Option Exercise | $11.51 | 4,000 | 46,040 | 14,300 | Sep 28, 2020, 06:12 PM |
Lochner Daniel | Chief Financial Officer | Aug 11, 2020 | Option Exercise | $11.51 | 4,000 | 46,040 | 10,300 | Aug 18, 2020, 06:18 PM |
Lochner Daniel | Chief Financial Officer | Aug 11, 2020 | Option Exercise | $11.51 | 4,000 | 46,040 | 4,000 | Aug 12, 2020, 08:32 PM |
Snisarenko John | Chief Commercial Officer | Aug 10, 2020 | Buy | $25.97 | 4,000 | 103,880 | 7,000 | Aug 11, 2020, 04:03 PM |
Nau Jeffrey | President and CEO | Jul 28, 2020 | Option Exercise | $1.02 | 5,000 | 5,100 | 5,000 | Jul 30, 2020, 07:37 PM |
InvOpps GP IV, L.L.C. | Director | May 19, 2020 | Buy | $28.00 | 178,571 | 4,999,988 | 1,850,818 | May 21, 2020, 05:00 PM |
InvOpps GP IV, L.L.C. | Director | Nov 04, 2019 | Buy | $16.00 | 750,000 | 12,000,000 | 1,731,425 | Nov 06, 2019, 04:30 PM |
Snisarenko John | Chief Commercial Officer | Nov 04, 2019 | Buy | $16.00 | 3,000 | 48,000 | 3,000 | Nov 05, 2019, 06:08 AM |
Lochner Daniel | Chief Financial Officer | Nov 04, 2019 | Buy | $16.00 | 6,300 | 100,800 | 6,300 | Nov 05, 2019, 06:08 AM |
Nau Jeffrey | President and CEO | Nov 04, 2019 | Buy | $16.00 | 1,000 | 16,000 | 1,000 | Nov 05, 2019, 06:05 AM |
Vida Ventures, LLC | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 185,000 | 2,960,000 | 963,468 | Nov 04, 2019, 07:04 PM |
Falcon Vision LLC | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 155,000 | 2,480,000 | 1,039,622 | Nov 04, 2019, 06:19 PM |
KKR Fund Holdings L.P. | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 155,000 | 2,480,000 | 1,039,622 | Nov 04, 2019, 06:17 PM |
New Enterprise Associates 14, L.P. | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 935,000 | 14,960,000 | 5,925,287 | Nov 04, 2019, 06:04 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 437,500 | 7,000,000 | 1,003,658 | Nov 04, 2019, 05:58 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 125,000 | 2,000,000 | 2,561,888 | Nov 04, 2019, 05:58 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2019 | Buy | $16.00 | 27,500 | 440,000 | 2,002,298 | Nov 04, 2019, 05:58 PM |
Ozawa Clare | Director | Nov 04, 2019 | Buy | $16.00 | 562,500 | 9,000,000 | 2,561,888 | Nov 04, 2019, 05:54 PM |
LINK WILLIAM J PHD | Director | Nov 04, 2019 | Buy | $16.00 | 27,500 | 440,000 | 2,002,298 | Nov 04, 2019, 05:51 PM |
Owner | Relationship | Date | Value($) |
Nau Jeffrey | President and CEO | 01/29/2022 | 30,502 |
Lochner Daniel | Chief Financial Officer | 01/29/2022 | 10,975 |
Nau Jeffrey | President and CEO | 12/01/2022 | 100,106 |
Lochner Daniel | Chief Financial Officer | 12/01/2022 | 36,490 |
Nau Jeffrey | President and CEO | 12/01/2022 | 69,630 |
Lochner Daniel | Chief Financial Officer | 11/01/2021 | 98,871 |
Nau Jeffrey | President and CEO | 10/21/2021 | 51,000 |
Versant Venture Capital VI, L.P. | 10% Owner | 10/18/2021 | 8,160,736 |
LINK WILLIAM J PHD | Director | 10/18/2021 | 8,160,736 |
Ozawa Clare | Director | 10/18/2021 | 8,160,736 |
Lochner Daniel | Chief Financial Officer | 09/02/2021 | 86,325 |
Nau Jeffrey | President and CEO | 09/01/2021 | 10,200 |
Lochner Daniel | Chief Financial Officer | 07/28/2021 | 86,325 |
Nau Jeffrey | President and CEO | 04/02/2021 | 10,200 |
Lochner Daniel | Chief Financial Officer | 02/24/2021 | 104,845 |
Nau Jeffrey | President and CEO | 02/19/2021 | 10,200 |
Lochner Daniel | Chief Financial Officer | 09/25/2020 | 46,040 |
Lochner Daniel | Chief Financial Officer | 08/11/2020 | 46,040 |
Lochner Daniel | Chief Financial Officer | 08/11/2020 | 46,040 |
Snisarenko John | Chief Commercial Officer | 08/10/2020 | 103,880 |
Nau Jeffrey | President and CEO | 07/28/2020 | 5,100 |
InvOpps GP IV, L.L.C. | Director | 05/19/2020 | 4,999,988 |
InvOpps GP IV, L.L.C. | Director | 11/04/2019 | 12,000,000 |
Snisarenko John | Chief Commercial Officer | 11/04/2019 | 48,000 |
Lochner Daniel | Chief Financial Officer | 11/04/2019 | 100,800 |
Nau Jeffrey | President and CEO | 11/04/2019 | 16,000 |
Vida Ventures, LLC | 10% Owner | 11/04/2019 | 2,960,000 |
Falcon Vision LLC | 10% Owner | 11/04/2019 | 2,480,000 |
KKR Fund Holdings L.P. | 10% Owner | 11/04/2019 | 2,480,000 |
New Enterprise Associates 14, L.P. | 10% Owner | 11/04/2019 | 14,960,000 |
Versant Venture Capital VI, L.P. | 10% Owner | 11/04/2019 | 7,000,000 |
Versant Venture Capital VI, L.P. | 10% Owner | 11/04/2019 | 2,000,000 |
Versant Venture Capital VI, L.P. | 10% Owner | 11/04/2019 | 440,000 |
Ozawa Clare | Director | 11/04/2019 | 9,000,000 |
LINK WILLIAM J PHD | Director | 11/04/2019 | 440,000 |